May 10 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 4.92 4.61 5.20 2.60
(+6.7 pct) (+8.4 pct) (+5.6 pct) (+3.5 pct)
Operating 821 mln 747 mln 850 mln 425 mln
(+9.8 pct) (+18.3 pct) (+3.5 pct) (-16.9 pct)
Recurring 853 mln 777 mln 850 mln 425 mln
(+9.8 pct) (+19.0 pct) (-0.5 pct) (-19.4 pct)
Net 568 mln 512 mln 570 mln 285 mln
(+10.9 pct) (+22.7 pct) (+0.3 pct) (-20.6 pct)
EPS 136.13 yen 126.39 yen 136.56 yen 68.28 yen
Ann Div 25.00 yen 25.00 yen 25.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 25.00 yen 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T